News

Calidi Biotherapeutics, Inc. ('Calidi” or the 'Company”) (NYSE American: CLDI), a clinical-stage biotechnology company pioneering the development of targeted therapies with the potential to deliver ...
But with HIV, we haven't got a solution to the problem yet," he said. An HIV infection is so difficult to cure because the virus is incredibly effective at hiding in our cells. When HIV infects our ...